4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-25-033063
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rubin Steven D · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-24 | Grant or award : show line 1 in the form Stock Option (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X05/wk-form4_1750897763.xml…